Search by Medical Condition
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for Obesity, Abdominal
- Exploratory Evaluation of the Effect of Cholestyramine on Serum Levels of POPs in Obese Female Patients
- Effects of GLP-1RA on Body Weight, Metabolism and Fat Distribution in Overweight/Obese Patients With Type 2 Diabetes Mellitus
- Effects of Berberine on Preventing Cardiovascular Disease and Diabetes Mellitus
- Evaluation of Milk Polar Lipids in Dyslipidemic Adults With Abdominal Obesity
- Effects of Berberine in Reducing Abdominal Visceral Adipose Tissue Among Individuals With Obesity and NAFLD
- A Study to Evaluate Safety, Tolerability of Subcutaneous Injection in Adult Subjects Undergoing Abdominoplasty
- ORAL ANTIDIABETICS EFFECT ON VISCERAL FAT
- Bioenergetic Effects of Aging and Menopause (BEAM)
- The Effect of Curcumin on Liver Fat Content in Obese Subjects
- The Effect of Intravenous Nalbuphine on PONV With Intrathecal Morphine in Abdominoplasty.
- Metformin Effect on Brain Function in Insulin Resistant Elderly People
- Growth Hormone Releasing Hormone Analog to Improve Nonalcoholic Fatty Liver Disease and Associated Cardiovascular Risk
- Vitamin D Supplementation on Metabolic Syndrome Indicators Among Older Adults, Alborz Province, Iran
- Impact of Liraglutide 3.0 on Body Fat Distribution
- Genomic Outcomes of Metformin
- Visceral Adiposity and Diabetes: Translating Form to Function Using Imaging
- Galantamine Effects in Patients With Metabolic Syndrome
- Aldosterone Antagonism and Microvascular Function
- Efficacy and Safety Study of ALS-L1023 in Patients With Abdominal Obesity of Metabolic Syndrome
- Abdominal Obesity, Cardiovascular Inflammation, and Effects of Growth Hormone Releasing Hormone Analogue
- Effects of Acipimox on Mitochondrial Function in Obesity
- The Effect of Moxonidine on Blood Pressure and Regression of Early Target Organ Damage in Young Subjects With Abdominal Obesity and Hypertension
- Pilot Study With GFT505 (80mg) in Patients Presenting With Impaired Glucose Tolerance and Abdominal Obesity.
- Pilot Study With GFT505 (80mg) in Patients With Insulin Resistance and Abdominal Obesity
- Pilot Study With GFT505 (80mg) in Atherogenic Dyslipidaemic Patients With Abdominal Obesity
- Metabolic Effects of an 8 Week Niaspan Treatment in Patients With Abdominal Obesity and Mixed Dyslipidemia
- Treatment of Adiposity Related hypErTension (TARGET)
- Rosuvastatin in Visceral Adiposity
- Growth Hormone Treatment in Men With High Risk of Developing Type 2 Diabetes Mellitus
- Effectiveness of Growth Hormone Releasing Hormone in Reducing Abdominal Fat in People Who Are Obese
- Effects of Aliskiren and Amlodipine on the Renin-Angiotensin System (RAS) and Lipid/Carbohydrate Metabolism in Obese Patients With Hypertension
- The Vascular Effects of Carvedilol Controlled Release (CR) in Abdominally Obese Hypertensive Patients
- Effect of Replacing HFCS With Sucromalt in Subjects With Raised Waist Circumference
- A Study to Evaluate CJC 1295 in HIV Patients With Visceral Obesity
- A Study of Safety and Efficacy of Topiramate in Male Patients With Abdominal Obesity